drugset / Trial / NCT07253272
A PET Study of ENX-104 in Healthy Volunteers
NaSequentialOpen-labelOther
Summary
The study is designed to evaluate the D2/D3 receptor occupancy (RO), safety, tolerability, and pharmacokinetics (PK) of ENX-104 in healthy volunteers.
Timeline
- Start
- 2025-02-24
- Primary completion
- 2025-09-02
- Completion
- 2025-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ENX-104 | Unknown | — | Oral |
Indications
No indication recorded.